Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07901114
PHASE1
A Bioequivalence and Safety Study of AJU-C719 and C719R in Healthy Adult Volunteers
Sponsor: AJU Pharm Co., Ltd.
View on ClinicalTrials.gov
Summary
To evaluate the bioequivalence and safety of "AJU-C719" and "C719R" in healthy adult subjects.
Official title: A Randomized, Open-Label, Fasting, 2-Period, 2-Sequence Crossover Study to Evaluate the Bioequivalence and Safety of AJU-C719 and C719R in Healthy Adult Volunteers
Key Details
Gender
All
Age Range
19 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2026-11
Completion Date
2026-12
Last Updated
2026-10-28
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Test Drug
AJU-C719
DRUG
Reference Drug
C719R
Locations (1)
Bumin Hospital (Seoul)
Seoul, Seoul, South Korea